Funding for this research was provided by:
National Institutes of Health (1U54HD090259-01)
Article History
Received: 30 March 2019
Accepted: 23 August 2019
First Online: 3 September 2019
Compliance with ethical standards
:
: Dr. Capparelli serves on the data safety and monitoring board for Cempra Pharmaceuticals and Celltrion. Dr. Nikanjam and Dr. Yang have no potential conflicts of interest.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.